• Skip to main content

Is GMO weed inevitable, given Big Ag’s entry into the cannabis industry?

Published: May 15, 2017, 12:06 pm • Updated: May 15, 2017, 12:06 pm

By Will Houston, Eureka Times-Standard

Genetically modified marijuana is a term that may strike fear into the cannabis farms in the hills of Humboldt County, conjuring visions of large agricultural companies like Monsanto entering the commercial market with enhanced strains.

While these genetically altered strains have yet to find their way into the marketplace, according to agricultural officials, some who study the cannabis genome such as Dr. Reggie Gaudino of the Berkeley-based Steep Hill cannabis laboratory say it’s only a matter of time before they do.

“The cannabis industry should be aware that sooner rather than later, there will be big ag at play in this industry,” Gaudino said Friday. “And big ag uses exactly these techniques. We’re working to help the current population of farmers and breeders retain relevance when big ag comes knocking on the door.”

After the passage of Proposition 64, local farmers have two years to press their advantage before companies outside the state can enter the cannabis market and until 2022 before grow sizes can reach above an acre.

Other researchers like Phylos Bioscience’s CEO Mowgli Holmes in Oregon disagree with Gaudino, stating that the industry and consumers are not as willing to accept or would even want to associate genetically modified organisms, known also as GMOs, with cannabis.

“I don’t think there is any thing that GMOs could do for cannabis that we need that couldn’t be done by advanced plant breeding techniques,” Holmes said. “GMOs can make cannabis that glows in the dark, but we don’t need that.”

Areas like Humboldt County have already worked to distance themselves from any GMO cannabis market that may arise and are instead working to embrace a regulated industry of environmentally conscious and organic farming practices.

Chromosomes of cannabis

Within marijuana’s 20 chromosomes are what some researchers say is the future of cannabis breeding waiting to be unlocked through the field of genomics.


Dr. Reggie Gaudino, foreground, of the Berkeley-based Steep Hill commercial cannabis laboratory stands next to his PacBio DNA sequencer. (Photo by Elizabeth Peace; Contributed by Steep Hill)

Labs like Phylos Bioscience and Steep Hill formed within the past decade are now using DNA sequencing techniques on various strains of cannabis to begin to unlock what makes marijuana tick. Labs are able to tests for different markers in marijuana’s DNA that coincide with the number of terpenes or the non-psychoactive cannabinoid, known as CBD.

“We have a big map of all the varieties that we’ve ever sequenced,” Holmes said. “It positions the sample on that so it’s near other things it’s genetically related to. Then there is a back report page that gives information on what population may have contributed genes to it. In the future we’ll have genetic tests that will tell people what traits the plant will have as it gets older.”

Gaudino said the work to map the marijuana genome is just in its nascent stages, but that its relevance in the modern market is already at work.

“Using the human genome as an example, that took 13 years, $3 billion and 11,500 sequences to arrive at what we call the human genome,” Gaudino said. “This is just starting for cannabis. There is no quote-unquote cannabis genome yet. In order to develop that you have to sequence lots of different strains.”

While marijuana has grown more potent than strains smoked at 1960s music festivals, these stronger strains are not the result of genetic modification — to most people’s knowledge — but rather tried and true traditional breeding techniques such as hybridization and cross-breeding.

Marijuana farmers like Mom and Pop Gardens co-owner Nicholas — who declined to give his last name — in northeastern Humboldt County states he is a proponent of naturally grown cannabis, stating that breeding has diluted the resiliency of certain types of strains. Even so, Nicholas said he is not entirely against a genetically-modified product.

“If the people that did GMO put the 20 to 40 years of research into this and verified their products were OK, that it didn’t harm people or animals, they might be OK,” he said.

While cloning may seem like a type of genetic modification, it does not fall under that category as it does not involve direct manipulation of the plant’s DNA. Even so, these techniques come with their own issues.

“Some people in the industry believe that cloning has been responsible for perpetuating a lot of the disease issues that you see in the cannabis industry,” Humboldt and Trinity counties’ Agricultural Commissioner Jeff Dolf said.

Future of GMO cannabis

Enzymes are what ultimately work to form marijuana’s aromatic and flavorful terpenes and cannabinoid components like CBD and the psychoactive THC. But some cannabinoids, like the lesser known non-psychoactive CBG, are harder to come by.

“Generally speaking, you can only get elevated amounts of CBG if there is something wrong with the enzymes that make THC or CBD or they are missing,” President and chief scientist Samantha Miller of the Santa Rosa-based Pure Analytics laboratory said.


A medical marijuana farm in Mendocino County in 2010. (Dan Rosenstrauch/Staff)

Miller said genetic modification technology like the CRISPR-Cas9 could certainly be used on cannabis to obtain different levels of cannabinoids and terpenes.

Whether farmers like it or not, Gaudino says genetic modification is coming and if utilized correctly, will work to benefit the industry in the long run. But Gaudino also said what matters is how genetic modification is used, and that he would be wary of creating more drought resistant strains or causing the plant to produce more sugar or proteins.

“The future is not necessarily a bad thing in respect to genetics of cannabis. It’s a matter of understanding what you can do with it,” he said. “I think a lot of people are afraid of it because of genetics. Really it’s something that all agriculture does because it makes sense, because we have the tools and the technology and can do things in a more cost effective, intelligent manner. That doesn’t necessarily mean we’re giving up the farm.”

Holmes is on the opposite end of the spectrum and said he has no interest in genetically modifying marijuana. He argues that increased understanding of marijuana’s genome can work to improve plant breeding techniques.

“People have been doing cross breeding and hybridization, but they haven’t been doing it in a scientific way,” he said. “It needs a lot of rapid evolution to be commercially viable as the industry gets more crowded.”

Organicannabis

Under the current federal prohibition of cannabis, consumers are not going to be seeing any certified organic strains on the shelves of dispensaries any time soon.

But there are other types of certifications that mimic federal organic standards, such as the Clean Green, Global Culture and the Eugene, Oregon-based Certified Kind.


Marijuana samples on display during Emerald Exchange in Malibu on March 18. The all-day cannabis event emphasizes organic, sun-grown cannabis. (Photo by Drew A. Kelley, Contributing Photographer)

Marijuana growers seeking these certifications must prove they follow rigorous environmental standards such as refraining from using pesticides and herbicides, generators, illegal diversions and certain types of soils to name a few.

So far only 24 farms are certified. Certified Kind’s founder and certification Director Andrew Black admits the standard is high, but for good reason.

“Part of what we’re doing is trying to build a movement to promote true organic cannabis farmers to protect small organic family farmers and create a marketplace for them in which they can compete and they can call the shots,” Black said. “I see organic cannabis as part of the resistance to big farm and big pharma.”

California’s own medical marijuana regulations also call for the creation of an organic certification program by 2020, but only if the federal government permits it.

In the meantime, Humboldt County created its own organic-equivalent called “Humboldt Artisinal Branding.”

To qualify, growers must have both state and local cultivation permits, only grow 3,000 square feet or less of plant canopy, grow exclusively with natural light and meet all federal organic certification standards.

“It’s not difficult to take what we do for all the other organic commodities and apply them to cannabis,” Dolf said. “We can’t call it organic because it’s a federal term. We already have a pretty good understanding of the principles that need to be followed for the principles to be considered organic.”

This story was first published on TheCannifornian.com

Thousands expected to attend Canada’s largest cannabis trade show to prep for legalization

Published: May 15, 2017, 10:21 am • Updated: May 15, 2017, 10:28 am

By Tess Allen, Civilized

At its core, the Lift Cannabis Expo is all about “stimulating conversation.”

“The industry today is where it is because of the [decades] of advocacy and patient rights that have pushed this legislation forward,” said Lift CEO Matei Olaru, referring to the recently announced federal legislation to legalize recreational cannabis by July 1, 2018.

Of course, that’s not the only goal of Canada’s biggest cannabis trade show, slated for May 26-28 in Toronto. The second annual expo organized by Lift – Canada’s largest cannabis media and technology company – will feature nearly 200 exhibitors from around the world offering education, innovation and opportunities to the thousands of consumers, patients, healthcare professionals, investors and cannabis professionals set to descend upon the Metro Toronto Convention Centre.

Last year’s Toronto expo saw more than 10,000 people over two days.

Read more of this story at Civilized

This story was first published on Civilized.Life

Florida dispensary says new flower product doesn’t violate smoking ban

Published: May 15, 2017, 8:01 am • Updated: May 15, 2017, 8:06 am

By Joe Reedy, The Associated Press

TALLAHASSEE, Fla. — A Florida medical marijuana dispensary says it is not violating state law by selling cannabis that could potentially be broken down and made into pot that can be smoked.

Trulieve began selling its first whole-flower cannabis product earlier this week that is meant for vaping. The buds in the vaporizer cup, however, could be also be used in joints, pipes or bongs.

Vaping is allowed under state law but smoking is prohibited. Trulieve CEO Kim Rivers said the company has issued warnings to patients that the product should only be used for vaping.

Department of Health spokeswoman Mara Gambinieri said the product was approved by the Office of Compassionate Use but that they are keeping a close eye on this one. Gambinieri added that dispensaries are held to the product descriptions made in applications.

All six of Florida’s distributing organizations that are authorized to sell cannabis have vaping products. Trulieve is the first that is selling a whole-flower product. Other vaping products use cannabis that is ground up.

According to the Department of Health, 80 percent of cannabis sales are vaping.

Medical marijuana supporters have advocated for whole-flower use because of what is called the entourage effect, which means all the various compounds are working together instead of separately.

With two months remaining until rules for medical marijuana Amendment 2 are supposed to be enacted, whether or not smoking will be permitted remains one of many issues that needs to be sorted out by the Legislature or Department of Health.

The Legislature wants to ban smoking but John Morgan, the Orlando attorney who was one of the key figures in getting the amendment passed last November, said he would sue if the new rules did not allow smoking. The rules are supposed to be in place in July and implemented in October.

“For them not to allow smoking, that is the opposite of what the amendment says. The only place where it says it can’t be smoked is public places,” he said.

Sen. Rob Bradley, a Republican from Orange Park, said the Legislature opposes smoking because it is an unhealthy act.

The Legislature is considering holding a special session to complete work on a rules bill that collapsed the last week of session. If they don’t, the Department of Health would write the rules.

Sessions’ war on drugs has medical marijuana advocates worried

Published: May 15, 2017, 7:38 am • Updated: May 15, 2017, 7:39 am

By John Wagner and Matt Zapotosky, The Washington Post

WASHINGTON – A little-noticed document issued by President Donald Trump has put advocates of medical marijuana on edge, raising questions about the long-term security of programs now authorized in 29 states and the District that have broad public backing.

In a “signing statement” that accompanied Trump’s signature on the bill passed this month to keep the government open, the president noted a handful of objections on legal grounds, including to a provision that prohibits his administration from interfering with state-run medical marijuana programs.

White House aides indicated that none of Trump’s objections to Congress’s work signaled immediate policy changes. But given how vocal Attorney General Jeff Sessions has been toward relaxing marijuana restrictions, those who support the burgeoning industry are worried about what could come next.

“It just creates a lot of uncertainty, and that uncertainty is deeply concerning for patients and providers,” said Michael Collins, deputy director of the Drug Policy Alliance, an organization that has sought to roll back the nation’s war on drugs. “We had thought medical marijuana wasn’t really in play in terms of a crackdown.”

Such concerns are being voiced more broadly about the direction of marijuana policy under the new leadership at the Justice Department.

Sessions last week directed federal prosecutors to get significantly tougher on drug defendants than under the Obama administration. And a task force launched by Sessions is looking at changes in enforcement particularly regarding marijuana, a drug that remains illegal on the federal level despite significant movement in numerous states in recent years to loosen restrictions.

The eight states that have legalized marijuana for recreational use could be at greater risk for federal intervention than those that have only approved dispensing medical cannabis or cannabis-infused products to patients with a doctor’s recommendation.

As a candidate for president, Trump repeatedly voiced support for medical marijuana, a concept that has been increasingly embraced by fellow Republicans at the state level. Of the 29 states that have authorized programs, Trump prevailed in last year’s election over Democrat Hillary Clinton in nine of them.

Meanwhile, a Quinnipiac poll last month found that 94 percent of Americans – including 90 percent of Republicans – supported allowing adults to legally use marijuana for medical purposes if their doctors prescribe it.

White House press secretary Sean Spicer said earlier this year that he expects states to be subject to “greater enforcement” of federal laws against marijuana use, though he also said Trump sees “a big difference” between use of marijuana for medical purposes and for recreational purposes.

Sessions, however, said at an appearance in Richmond, earlier this year, that medical marijuana “has been hyped, maybe too much.”

A Justice Department spokesman declined to discuss what future steps might be taken related to medical marijuana but said the provision in the spending bill is of concern to officials.

“The Department of Justice must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives,” said spokesman Ian Prior, who wouldn’t discuss the issue further.

Justin Strekal, political director for the National Organization for the Reform of Marijuana Laws, said the May 5 signing statement is troubling, even if a federal crackdown is not in the offing, because it could have “a chilling effect on a nascent industry.”

Of particular concern, he said, is the impact it could have on investors in dispensaries in states where programs are just coming on line. A prosecution of a single business in one state could have a devastating impact in that regard, he added.

The provision in question, which has been part of federal law since late 2014, prohibits the Justice Department from spending money to interfere with state medical marijuana programs. It was co-authored by Rep. Dana Rohrabacher, R-Calif., who, by his own description, is “a very strong supporter” of Trump.

“I will treat this provision consistently with my constitutional responsibility to take care that the laws be faithfully executed,” Trump wrote in the signing statement.

Signing statements became prevalent under President George W. Bush and have often been used to preserve objections rather than to signal new action.

President Barack Obama continued the practice, routinely citing provisions in spending bills that he said conflicted with authority granted to him under the constitution.

Trump also objected on constitutional grounds to several other sections of the first spending bill he signed, including one related to a program that helps historically black colleges and universities get low-cost construction loans. That prompted an outcry from African American lawmakers, prompting Trump to release a statement about his commitment to HBCUs.

Tom Angell, founder of Marijuana Majority, said comments from Trump and the Justice Department on medical marijuana “doesn’t necessarily mean a crackdown is coming, but it’s a concerning signal.”

“Essentially [Trump is] saying he reserves the right to ignore this congressionally approved provision,” Angell said.

If the administration moves in that direction, it won’t be without a fight, Rohrabacher said.

The congressman, who has used cannabis himself to ease pain from severe arthritis in his shoulders caused by years of surfing, said he’s confident his side would prevail in court because Congress clearly has “the power of the purse.”

Rohrabacher said it appears that members of Trump’s administration are working to “reposition” him on the issue of medical marijuana.

“I think there are a lot of people running around trying to paint the president into a corner on this,” Rohrabacher said, adding that he is eager to talk to Trump about it directly.

In August 2016, the U.S. Court of Appeals for the 9th Circuit ruled a similar provision passed by Congress prevented the Justice Department from spending money on prosecutions in states where medical marijuana was legal – so long as those being prosecuted abided by state law.

More broadly, James Cole, a deputy attorney general in the Obama administration, had directed prosecutors to enforce all federal drug laws – even in places that had legalized marijuana – but said they should look to states’ regulatory systems to determine whether their intervention was necessary.

Cole wrote that federal authorities should essentially stay out of states that had robust regulatory systems in place.

Cole’s memo is among the policies now being actively reviewed by the new leadership at the Justice Department.

The issue of medical marijuana will need to be revisited again by Congress in coming months. The provision sponsored by Rohrabacher expires on Sept. 30, at the end of the federal fiscal year, and would have to be adopted again to stay on the books.

DEA raids illegal marijuana grow across street from Colorado elementary school

Published: May 12, 2017, 6:44 pm • Updated: May 15, 2017, 8:57 am

By Kaitlin Durbin, The Gazette

A woman living in Monument, Colorado’s upscale King’s Deer neighborhood said she was relieved that her many calls about a marijuana grow across from an elementary school didn’t fall on deaf ears.

She watched Friday as Drug Enforcement Administration agents raided her neighbor’s home at 19150 Breton Place, removing 4- to 7-foot plants and piling them 3 feet high in the driveway.

“To do that right next to a school in a house so open, I just think that’s so bold of them,” said the woman, who asked not to be identified.

The early morning raid was part of a federal investigation into drug trafficking, said Jeff Dorschner, spokesman for the U.S. Attorney’s Office. He could not provide details, but the DEA tweeted that the grow is part of an out-of-state operation. It wasn’t clear whether agents had made arrests.

Read more of this story at The Colorado Springs Gazette

This story was first published on Gazette.com

NASCAR nixes weed company logo from driver’s car

Published: May 12, 2017, 6:07 pm • Updated: May 12, 2017, 6:09 pm

By The Associated Press

KANSAS CITY, Kan. — Carl Long was forced to strip the logo of a Colorado-based marijuana vaping company from his car Friday after NASCAR said it violated rules governing sponsorship and paint schemes.

The logo for Colorado-based Veedverks was plastered on Long’s green and yellow No. 66 for tech inspection, but a NASCAR spokesman said it was never vetted and approved. And when officials learned of the hood logo, they had crew members remove it before the car went to the track.

NASCAR officials said it will not adorn the car the rest of the weekend.

Long returned to NASCAR’s top series this weekend after an eight-year banishment over an unpaid fine from a rules infraction earlier in his career. The penalty was commuted by NASCAR this season.

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Interim pages omitted …
  • Page 46
  • Go to Next Page »
Access Politics Health Higher Learning
Licensed Producers Dispensaries Clinics

Cultivate Change © 2026 WeedHub | info@weedhub.ca